Elisa became part of the Okairos team in 2010 and served as the company’s Clinical Director.
Prior to Okairos, she was a Scientist at IRBM / Merck since 1992, where she worked first in Hepatitis C infection and immunity and then as group leader in Oncology. She has been involved in many aspects of Vaccine programs, from the validation of the genetic vaccine platform in pre-clinical models to the design and implementation of clinical trials and the preparation of dossiers for regulatory agencies. In the past, she also carried out research at the ZMBH in Heidelberg working in the field of malaria infection.
She has published several papers in peer reviewed international journals.
Elisa has a degree in Medicine, residency in Hematology and master in Scientific and regulatory perspectives of drugs development.